Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings data on Thursday. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01, Bloomberg Earnings reports. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same period last year, the company earned $1.10 earnings per share. The firm’s revenue was up 7.9% compared to the same quarter last year. Walgreens Boots Alliance updated its FY18 guidance to $5.45-5.70 EPS.
Shares of Walgreens Boots Alliance (WBA) traded down $3.91 during trading on Friday, reaching $71.60. The company’s stock had a trading volume of 12,455,200 shares, compared to its average volume of 8,735,833. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance has a 12-month low of $63.82 and a 12-month high of $88.00. The firm has a market capitalization of $72,040.00, a PE ratio of 19.78, a PEG ratio of 1.35 and a beta of 1.22.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were paid a $0.40 dividend. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 44.20%.
In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.
Several large investors have recently made changes to their positions in WBA. Hudock Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Flagship Harbor Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 0.5% in the first quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock valued at $243,000 after buying an additional 16 shares during the period. Guardian Life Insurance Co. of America raised its stake in shares of Walgreens Boots Alliance by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 3,301 shares of the pharmacy operator’s stock valued at $274,000 after buying an additional 22 shares during the period. Northern Capital Management LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after buying an additional 25 shares during the period. Finally, MAI Capital Management raised its stake in shares of Walgreens Boots Alliance by 0.6% in the second quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock valued at $413,000 after buying an additional 34 shares during the period. 61.18% of the stock is currently owned by institutional investors.
A number of equities analysts have recently issued reports on the company. Needham & Company LLC lowered their price objective on Walgreens Boots Alliance to $86.00 and set a “buy” rating for the company in a research report on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, October 29th. Pivotal Research set a $73.00 target price on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Finally, BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, eight have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance presently has an average rating of “Buy” and an average target price of $86.05.
TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Posts Earnings Results, Beats Estimates By $0.01 EPS” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3126731/walgreens-boots-alliance-wba-posts-quarterly-earnings-results-beats-expectations-by-0-04-eps.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.